Buckingham Capital Management (Ohio)’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-14,595
Closed -$33K 127
2020
Q3
$33K Buy
14,595
+440
+3% +$1.26K 0.01% 113
2020
Q2
$51K Sell
14,155
-740
-5% -$2.67K 0.01% 115
2020
Q1
$57K Sell
14,895
-170
-1% -$560 0.01% 121
2019
Q4
$45K Buy
+15,065
New +$39.2K 0.01% 131

Other funds holding BMY.RT

Buckingham Capital Management (Ohio)'s BMY.RT Position: Q4 2020 in Review

Buckingham Capital Management (Ohio) sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q4 2020, closing a stake of 14,595 shares — an estimated $33K sold.

Buckingham Capital Management (Ohio) first reported a position in BMY.RT in Q4 2019 and held it in 4 quarters. The position peaked at $57K in Q1 2020. 546 funds tracked by Wall St. Rank hold BMY.RT as of Q4 2020.

  • Buckingham Capital Management (Ohio) reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q4 2020 after selling out during the quarter.
  • Buckingham Capital Management (Ohio) sold 14,595 Bristol-Myers Squibb Company Contingent Value Rights shares in Q4 2020, an estimated $33K.
  • Buckingham Capital Management (Ohio) first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 4 quarters.
  • Buckingham Capital Management (Ohio)'s Bristol-Myers Squibb Company Contingent Value Rights position peaked at $57K in Q1 2020.
  • 546 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q4 2020.

Based on Buckingham Capital Management (Ohio)'s 13F filing for Q4 2020, filed 4 Feb 2021.